Free Trial

Ardent Health Partners (ARDT) Stock Price, News & Analysis

Ardent Health Partners logo
$15.10 -0.05 (-0.33%)
As of 05/20/2025 03:58 PM Eastern

About Ardent Health Partners Stock (NYSE:ARDT)

Key Stats

Today's Range
$14.98
$15.27
50-Day Range
$11.61
$15.40
52-Week Range
$11.31
$20.72
Volume
114,845 shs
Average Volume
395,705 shs
Market Capitalization
$2.16 billion
P/E Ratio
9.26
Dividend Yield
N/A
Price Target
$20.67
Consensus Rating
Buy

Company Overview

Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.

Ardent Health Partners Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
65th Percentile Overall Score

ARDT MarketRank™: 

Ardent Health Partners scored higher than 65% of companies evaluated by MarketBeat, and ranked 394th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Ardent Health Partners has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 9 buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Ardent Health Partners has only been the subject of 4 research reports in the past 90 days.

  • Read more about Ardent Health Partners' stock forecast and price target.
  • Earnings Growth

    Earnings for Ardent Health Partners are expected to grow by 59.35% in the coming year, from $1.23 to $1.96 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Ardent Health Partners is 9.26, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.97.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Ardent Health Partners is 9.26, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.83.

  • Short Interest

    There is no current short interest data available for ARDT.
  • Dividend Yield

    Ardent Health Partners does not currently pay a dividend.

  • Dividend Growth

    Ardent Health Partners does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for ARDT.
  • News Sentiment

    Ardent Health Partners has a news sentiment score of 0.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.65 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for Ardent Health Partners this week, compared to 4 articles on an average week.
  • Search Interest

    Only 1 people have searched for ARDT on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added Ardent Health Partners to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
Receive ARDT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ardent Health Partners and its competitors with MarketBeat's FREE daily newsletter.

ARDT Stock News Headlines

White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
Leerink Partnrs Brokers Lower Earnings Estimates for ARDT
Leerink Partnrs Issues Negative Estimate for ARDT Earnings
See More Headlines

ARDT Stock Analysis - Frequently Asked Questions

Ardent Health Partners' stock was trading at $17.08 at the start of the year. Since then, ARDT stock has decreased by 11.6% and is now trading at $15.10.
View the best growth stocks for 2025 here
.

Ardent Health Partners, LLC (NYSE:ARDT) announced its quarterly earnings data on Tuesday, May, 6th. The company reported $0.29 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.21 by $0.08. The business had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.50 billion.
Read the conference call transcript
.

Ardent Health Partners (ARDT) raised $192 million in an IPO on Thursday, July 18th 2024. The company issued 12,000,000 shares at $16.00 per share.

Top institutional investors of Ardent Health Partners include Vanguard Group Inc. (0.93%), Millennium Management LLC (0.67%), Allspring Global Investments Holdings LLC (0.57%) and Goldman Sachs Group Inc. (0.54%).

Shares of ARDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ardent Health Partners investors own include Broadcom (AVGO), 4D Molecular Therapeutics (FDMT), Mirum Pharmaceuticals (MIRM), Micron Technology (MU), Uber Technologies (UBER), Advanced Micro Devices (AMD) and ASML (ASML).

Company Calendar

Last Earnings
5/06/2025
Today
5/21/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
General medical & surgical hospitals
Sub-Industry
Healthcare
Current Symbol
NYSE:ARDT
Previous Symbol
NYSE:ARDT
Web
N/A
Fax
N/A
Employees
24,200
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$20.67
High Stock Price Target
$25.00
Low Stock Price Target
$18.00
Potential Upside/Downside
+36.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
13 Analysts

Profitability

Trailing P/E Ratio
9.26
Forward P/E Ratio
12.28
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$6.02 billion
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$2.16 billion
Optionable
Optionable
Beta
N/A
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (NYSE:ARDT) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners